Wills Hughes-Wilson

Encouraging industry participation in the EU's Sixth Framework Programme: Issues, barriers and potential solutions

Wills Hughes-Wilson, 2004 .

Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?

Steven Simoens, Ad Schuurman, S. Simoens, 2012, Orphanet Journal of Rare Diseases.

European approval system for advanced therapies: good news for patients and innovators alike.

Wills Hughes-Wilson, D. Mackay, 2007, Regenerative medicine.

A company experience of the first MoCA pilot project

Wills Hughes-Wilson, 2014, Orphanet Journal of Rare Diseases.

A coordinated EU approach to informed access decisions: CAVOD process proposals – the possibility to turn concept into reality?

Wills Hughes-Wilson, 2012, Orphanet Journal of Rare Diseases.